Lubrizol Launches Tolerathane™ Thermoplastic Polyurethane (TPU) for Implantable Medical Devices

Share this story

CLEVELAND, OH – Lubrizol announces the launch of Tolerathane™ TPU, a new medical-grade material engineered to meet the evolving demands of implantable medical devices. Compared to other TPU materials, Tolerathane™ TPU offers unparalleled tolerance to harsh biological conditions while maintaining superior softness, mechanical resilience, and seamless integration into standard thermoplastics processing compared to currently available TPU materials.

Designed to help medical device OEMs reimagine what’s possible for implanted technologies, the thermoplastic nature and polyurethane mechanical properties of TOLERATHANE™ TPU open new possibilities for advanced device design for a range of applications. The product’s performance attributes closely align with the technical requirements of neuromodulation & cardiac leads, structural heart implants, percutaneous catheters and cables, and implanted textiles.

Performance Benefits

  • Boosted Biostability: Superior tolerance to oxidative and hydrolytic attack compared to currently available TPU materials
  • Softness without Sacrifice: Enhanced biostability at the softest durometers while offering good mechanical properties
  • Scaled for Customization: Seamlessly integrates with typical thermal processing methods and offers tunability for optimized performance
  • A Thermoplastic Alternative to Silicone: Enables thinner wall designs that support device miniaturization and design flexibility—transforming innovation in implantable medical device development.

“Lubrizol brings decades of foundational expertise to its specialized medical-grade TPU portfolio,” said Jennifer Green, Sr. Global Technical Business Development Manager and Commercial Lead for Tolerathane™ TPU. “As a pioneer in thermoplastic polyurethane innovation, Lubrizol continues to meet the evolving needs of modern healthcare—delivering materials that enable innovative medical devices and developing the next-generation TPU for implantable medical devices.”

Tolerathane™ TPU debuts at MD&M West 2026, North America’s largest medical design and manufacturing event, where Lubrizol showcases its latest innovations in medical-grade materials. Speak directly with technical experts about its potential to transform device design by visiting Booth 2301.

To learn more about Tolerathane™ TPU, contact your Lubrizol representative or visit lubrizol.com.

About The Lubrizol Corporation

Lubrizol, a Berkshire Hathaway company, is a science-based company whose specialty chemistry delivers sustainable solutions to advance mobility, improve well-being and enhance modern life. Every day, the innovators of Lubrizol strive to create extraordinary value for customers at the intersection of science, market needs and business success, driving discovery and creating breakthrough solutions that enhance life and make the world work better. Founded in 1928, Lubrizol has global reach and local presence, with more than 100 manufacturing facilities, sales and technical offices and more than 7,000 employees around the world. For more information, visit www.Lubrizol.com.

 

Leave a Comment

Your email address will not be published. Required fields are marked *

*